Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Cataract

Subspecialties Cataract

Clarity in Cataract Management

| Sponsored by Keeler

The Visiometrics HD Analyzer – for more personalized procedure selection and higher patient satisfaction

Subspecialties Cataract

Dousing the Post-Cataract Flames

| Rochelle Nataloni

Anti-inflammatories that reduce patient adherence or offer a more reliable delivery mechanism are driving the evolution of postoperative regimens

Subspecialties Cataract

Lifetimes of Innovation

| Sponsored by Bausch & Lomb

Bausch + Lomb reflects on a legacy of ophthalmic excellence – from the enVista® IOL platform to the Vitesse™ hypersonic vitrectomy system, and beyond

Subspecialties Cataract

Doubling Down on Virtual Surgery

| Harald P. Studer

Digital twin technology is enabling patient-specific surgery planning for optimal refractive outcomes

Subspecialties Cataract

The Digitalization and Personalization of Eye Care

| Sponsored by Optimo Medical

Software that models the eye and simulates surgery on a digital twin is revolutionizing cataract treatment

Subspecialties Refractive

The New Generation: Electronic IOLs

| Sponsored by SAV-IOL

Restoring vision using a smart, active intraocular lens for cataract surgery

Subspecialties Cataract

DEXYCU: Jason Bacharach

| Sponsored by EyePoint Pharmaceuticals

Jason Bacharach on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Subspecialties Cataract

DEXYCU: Mark Pyfer

| Sponsored by EyePoint Pharmaceuticals

Mark Pyfer on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Subspecialties Cataract

A NOD to Affirm Performance

| John Sparrow

The RCOphth National Ophthalmology Database (NOD) Audit can provide richer outcomes analysis than any single individual or institution – and cost less

Subspecialties Cataract

DEXYCU: Michael Savetsky

| Sponsored by EyePoint Pharmaceuticals

Michael Savetsky on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Newsletter

Send me the latest from The Ophthalmologist.

Sign up now

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register